AI
CLBT icon

Atom Investors’s Cellebrite CLBT Stock Holding History

Atom Investors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,916
Closed -$406K – 637
2025
Q1 		$406K Sell
20,916
-31,828
-60% -$670K 0.05% 323
2024
Q4 		$1.16M Buy
52,744
+7,479
+17% +$144K 0.14% 216
2024
Q3 		$762K Sell
45,265
-73,860
-62% -$1.1M 0.08% 282
2024
Q2 		$1.42M Buy
119,125
+10,051
+9% +$112K 0.14% 199
2024
Q1 		$1.21M Buy
109,074
+115
+0.1% +$1.17K 0.15% 198
2023
Q4 		$944K Buy
108,959
+81,794
+301% +$636K 0.17% 193
2023
Q3 		$208K Buy
+27,165
New +$204K 0.05% 371

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atom Investors's CLBT Position: Q2 2025 in Review

Atom Investors sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 20,916 shares — an estimated $406K sold.

Atom Investors first reported a position in CLBT in Q3 2023 and held it in 7 quarters. The position peaked at $1.42M in Q2 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Atom Investors reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Atom Investors sold 20,916 Cellebrite shares in Q2 2025, an estimated $406K.
  • Atom Investors first reported a position in Cellebrite in Q3 2023 and held it in 7 quarters.
  • Atom Investors's Cellebrite position peaked at $1.42M in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Atom Investors's 13F filing for Q2 2025, filed 14 Aug 2025.